Thorax · 2020 · 124 citations · 6 references
MedicineInfectious DiseasesRespiratory TherapyCritical Care Respiratory TherapyRespiratory PharmacotherapyVentilator ManagementAcute Respiratory Distress SyndromeAcute Respiratory FailureMechanical VentilationOxygen TherapyRespiratory DiseaseRespiratory FailureAcute Hypoxemic Respiratory FailureHigh-flow Nasal Cannula Oxygen TherapyHigh-flow Nasal Cannula SupportHigh-flow Oxygen TherapyIntubation-related HypoxemiaRespiratory Status AssessmentSars-cov-2 InfectionSevere Acute Respiratory Syndrome
This observational study aims to assess the outcome and safety of O 2 -therapy by high-flow nasal cannula (HFNC) in 28 consecutive patients with severe hypoxemic acute respiratory failure (hARF) consequent to SARS-CoV-2 infection, unresponsive to conventional O 2 -therapy. Nineteen patients had a positive response. Nine patients required escalation of treatment to non-invasive ventilation (five subsequently intubated). None of the staff had a positive swab testing during the study period and the following 14 days. Severity of hypoxemia and C reactive protein level were correlated with HFNC failure. These data suggest HFNC to be a safe treatment for less severe patients with SARS-CoV-2 hARF and efficacy will need to be assessed as part of a clinical trial.
6
Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.7K citations · Full text
Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi et al. · Intensive Care Medicine · 2020 · 2.2K citations · Full text
Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi et al. · Critical Care Medicine · 2020 · 1.6K citations · Full text